The exploratory Center for Cognitive Phenomics (CCP) aims to accelerate identification and efficient measurement of cognitive phenotypes across syndromes and across species to advance interdisciplinary research on neuropsychiatric therapeutics. Cognitive abnormalities have been identified in all major neuropsychiatric disorders, offer quantitative phenotypes for genomic studies and clinical trials, and provide strong bridging relations to neural systems models. The CCP will iteratively refine cognitive phenotypes in interdisciplinary research using neurobehavioral, neuroimaging, and neuropsychopharmacological approaches to provide translational validation of physiological endophenotypes. The CCP will coordinate activities of a large group of experts at UCLA and elsewhere to: (1) generate cross-disorder and cross-species catalogs of phenotypes; (2) develop a phenotype selection algorithm to identify the most promising candidates for research; (3) design a phenomics database for empirical data representation, data mining, and hypothesis testing; and (4) support proof of- concept pilot projects. To advance these aims the CCP will initiate core services for: High Throughput Cognitive Phenotyping; Neuroimaging; and Translational Neuropsychopharmacology. The CCP will initially leverage UCLA campus-wide resources to provide bridging infrastructure and expertise in: Genomics, Pharmacogenomics and Statistical Genetics; Biostatistics and Psychometrics; Bioinformatics; Clinical Trial Design and Regulatory Affairs; and Bioethics. The CCP aims to overcome bottlenecks in the discovery of treatments for neuropsychiatric syndromes that are caused by the use of traditional behavioral """"""""symptom"""""""" phenotypes, which are heterogeneous and overlapping, and difficult to translate to basic research. The long-term goal is establishment of a mature CCP that will provide the international research community with efficient, well validated phenotype assays; a cognitive phenomics data repository linked to genomics, proteomics, and other biological knowledge-bases; and novel strategies for interdisciplinary research on neuropsychiatric therapeutics. ? ?
| Anderson, Ariana; Wilcox, Marsha; Savitz, Adam et al. (2015) Sparse factors for the positive and negative syndrome scale: which symptoms and stage of illness? Psychiatry Res 225:283-90 |
| Pievani, Michela; Bocchetta, Martina; Boccardi, Marina et al. (2013) Striatal morphology in early-onset and late-onset Alzheimer's disease: a preliminary study. Neurobiol Aging 34:1728-39 |
| Elsworth, John D; Groman, Stephanie M; Jentsch, J David et al. (2012) Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration. Neuropharmacology 62:1442-52 |
| Raine, A; Yang, Y; Narr, K L et al. (2011) Sex differences in orbitofrontal gray as a partial explanation for sex differences in antisocial personality. Mol Psychiatry 16:227-36 |
| Fears, Scott C; Scheibel, Kevin; Abaryan, Zvart et al. (2011) Anatomic brain asymmetry in vervet monkeys. PLoS One 6:e28243 |
| Woods, Roger P; Fears, Scott C; Jorgensen, Matthew J et al. (2011) A web-based brain atlas of the vervet monkey, Chlorocebus aethiops. Neuroimage 54:1872-80 |
| Ghahremani, Dara G; Monterosso, John; Jentsch, J David et al. (2010) Neural components underlying behavioral flexibility in human reversal learning. Cereb Cortex 20:1843-52 |
| Bilder, R M; Sabb, F W; Cannon, T D et al. (2009) Phenomics: the systematic study of phenotypes on a genome-wide scale. Neuroscience 164:30-42 |
| Fears, Scott C; Melega, William P; Service, Susan K et al. (2009) Identifying heritable brain phenotypes in an extended pedigree of vervet monkeys. J Neurosci 29:2867-75 |
| Hamilton, Liberty S; Altshuler, Lori L; Townsend, Jennifer et al. (2009) Alterations in functional activation in euthymic bipolar disorder and schizophrenia during a working memory task. Hum Brain Mapp 30:3958-69 |
Showing the most recent 10 out of 32 publications
